LYVE1-expressing macrophages have been shown to have a role in maintaining a proangiogenic perivascular niche in cancer [38], and CCL2 is the primary chemokine responsible for the recruitment of angiogenic macrophages [76]. Here, CCL2 is linked to cancer.